E-DRUG: WHO updates patent information on sofosbuvir & ledipasvir for treating Hepatitic C Virus
-------------------------------------------------------------------------------------------------------------------------
Dear E-druggers,
WHO updates patent information on new hepatitis C treatments
WHO has published updated patent reports on sofosbuvir, ledipasvir and
daclatasvir.
For sofosbuvir the report includes data for a number of
countries for which information was directly retrieved from patent offices,
including ARIPO, Morocco, OAPI, Tunisia, Golf Cooperation Council,
Philippines, Brazil. The report on daclatasvir contains a full dataset for
the main compound patent.
Download patent landscapes here:
http://www.who.int/phi/implementation/ip_trade/ip_patent_landscapes/en/
regards
Peter Beyer
Tel: +41 22 791 2507
beyerp@who.int